These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10088223)

  • 1. [Biology of bronchial cancer. Anomalies of the cellular cycle].
    Larsen C
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S14-5. PubMed ID: 10088223
    [No Abstract]   [Full Text] [Related]  

  • 2. [New cell biology research on the development of bronchial cancer].
    Lorenz J
    Internist (Berl); 1994 Aug; 35(8):692-9. PubMed ID: 7960549
    [No Abstract]   [Full Text] [Related]  

  • 3. 3-Methylcholanthrene triggers the differentiation of alveolar tumor cells from canine bronchial basal cells and an altered p53 gene promotes their clonal expansion.
    TenHave-Opbroek AA; Shi XB; Gumerlock PH
    Carcinogenesis; 2000 Aug; 21(8):1477-84. PubMed ID: 10910947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-depth analysis of molecular alterations within normal and tumour tissue from an entire bronchial tree.
    Sikkink SK; Liloglou T; Maloney P; Gosney JR; Field JK
    Int J Oncol; 2003 Mar; 22(3):589-95. PubMed ID: 12579312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant transformation of mature cystic teratoma to squamous cell carcinoma involves altered expression of p53- and p16/Rb-dependent cell cycle regulator proteins.
    Iwasa A; Oda Y; Kurihara S; Ohishi Y; Yasunaga M; Nishimura I; Takagi E; Kobayashi H; Wake N; Tsuneyoshi M
    Pathol Int; 2008 Dec; 58(12):757-64. PubMed ID: 19067849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From dysplasia to cancer: cytologic, histopathologic and molecular aspects].
    Vignaud JM
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S107-11. PubMed ID: 10088273
    [No Abstract]   [Full Text] [Related]  

  • 9. Multi-step control of spindle pole body duplication by cyclin-dependent kinase.
    Haase SB; Winey M; Reed SI
    Nat Cell Biol; 2001 Jan; 3(1):38-42. PubMed ID: 11146624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bronchial cancer. Mechanisms of bronchial oncogenesis].
    Krespine C
    Soins; 1994 Dec-1995 Jan; (591-592):3-4, 6. PubMed ID: 7652603
    [No Abstract]   [Full Text] [Related]  

  • 11. A nonsynonymous single-nucleotide polymorphism in the PDZ-Rho guanine nucleotide exchange factor (Ser1416Gly) modulates the risk of lung cancer in Mexican Americans.
    Gu J; Wu X; Dong Q; Romeo MJ; Lin X; Gutkind JS; Berman DM
    Cancer; 2006 Jun; 106(12):2716-24. PubMed ID: 16691626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased osteonectin expression is associated with malignant transformation and tumor associated fibrosis in the lung.
    Siddiq F; Sarkar FH; Wali A; Pass HI; Lonardo F
    Lung Cancer; 2004 Aug; 45(2):197-205. PubMed ID: 15246191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pezcoller lecture: cancer cell cycles revisited.
    Sherr CJ
    Cancer Res; 2000 Jul; 60(14):3689-95. PubMed ID: 10919634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biology of bronchial cancer. Therapeutic modalities of the future. Apoptosis and gene therapy].
    Coll JL
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S17-8. PubMed ID: 10088225
    [No Abstract]   [Full Text] [Related]  

  • 15. Chromosomes in bronchial adenomas and in bronchogenic carcinomas.
    Falor WH
    Am Rev Respir Dis; 1971 Aug; 104(2):198-205. PubMed ID: 4326908
    [No Abstract]   [Full Text] [Related]  

  • 16. The p53 network in lung carcinogenesis.
    Robles AI; Linke SP; Harris CC
    Oncogene; 2002 Oct; 21(45):6898-907. PubMed ID: 12362272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle control and cancer.
    Sherr CJ
    Harvey Lect; 2000-2001; 96():73-92. PubMed ID: 12200872
    [No Abstract]   [Full Text] [Related]  

  • 18. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.
    Gorgoulis VG; Zacharatos P; Mariatos G; Liloglou T; Kokotas S; Kastrinakis N; Kotsinas A; Athanasiou A; Foukas P; Zoumpourlis V; Kletsas D; Ikonomopoulos J; Asimacopoulos PJ; Kittas C; Field JK
    Cancer Res; 2001 Jan; 61(2):538-49. PubMed ID: 11212247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and cellular biology of small cell lung cancer.
    Sattler M; Salgia R
    Semin Oncol; 2003 Feb; 30(1):57-71. PubMed ID: 12635090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of wild-type p53 activity enhances the sensitivity of pleural metastasis to cisplatin through an apoptotic mechanism.
    Riva CM
    Anticancer Res; 2000; 20(6B):4463-71. PubMed ID: 11205289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.